← Leaderboards
Scott T Miller
Suny Downstate Medical Center
$115,994
Attributed
$115,994
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $16.8K · FY2009–10$20K$15K$10K$5K$0
'09
'10
Funding mix
By agency
NIH$115,994 · 2
By mechanism
N01$115,994 · 2
Top collaborators
No co-investigators on record.
Most similar at Suny Downstate Medical Center
Same institution · by research overlap
- Scott Miller$333,283
- Brehon C Laurent$1,881,205
- Rena Orman$242,600
Others in their field
Top investigators on “Hydroxyurea”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Russell E Ware · Duke University$46,296,578
- Robert Turner Schooley · University Of Colorado Denver$42,688,650
- Charles A Coltman · Southwest Oncology Group$18,209,974
- Jay B Jackson · Johns Hopkins University$17,529,470
- Martin H. Steinberg · Boston Medical Center$12,744,665
Research focus
HydroxyureaSickle Cell AnemiaChemopreventionHuman Therapy EvaluationPreschool Child (1-5)Longitudinal Human StudyPathologic ProcessInfant Human (0-1 Year)Human SubjectBlood Disorder ChemotherapyMultiple Organ FailureClinical ResearchData SetCytogeneticsChildContractsContractorBest Pharmaceuticals For Children ActGrowth And Development FunctionFundingClinical TrialsFollow-UpFetal HemoglobinChronic
Grant awards (4)
Pediatric Hydroxyurea Phase III Clinical Trial$2,434
N01 · FY2010 · HL · contact PI
Pediatric Hydroxyurea Phase III Clinical Trial$16,834
N01 · FY2009 · HL · contact PI
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL$96,726
N01 · FY2000 · HB
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL$0
N01 · FY2000 · HB